Investment analysts at StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a research note issued on Tuesday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Stock Performance
Shares of SRNE opened at $0.01 on Tuesday. The business’s 50-day moving average price is $0.01 and its 200-day moving average price is $0.03. Sorrento Therapeutics has a twelve month low of $0.00 and a twelve month high of $0.42.
About Sorrento Therapeutics
Featured Stories
- Five stocks we like better than Sorrento Therapeutics
- ESG Stocks, What Investors Should Know
- AbbVie Stock: A Perfect Dip for Investors to Buy
- What is MarketRankā¢? How to Use it
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
- Stock Splits, Do They Really Impact Investors?
- GitLab Stock Rebounds: The Inside Story of Its Comeback
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.